Dr. Thomas F. Patterson received his Bachelor of Arts degree from Baylor University, in Waco, Texas and his medical degree from the University of Texas Medical School at Houston, Texas. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, Tennessee and at Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut where he also served as an Assistant Professor of Medicine.
Dr Patterson currently is a Professor of Medicine and Chief, Division of Infectious Diseases at the University of Texas Health Science Center in San Antonio, Texas. He is also Director of the San Antonio Center for Medical Mycology.
He has extensive experience in opportunistic fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases, particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds.
Dr Patterson has published and lectured extensively on fungal infections. He is a past member of the ICAAC and IDSA Program Committees and is Editor-in-Chief of the popular mycology website www.doctorfungus.org. He is a member of the American Board of Internal Medicine, Subspecialty Committee for Infectious Diseases. He is a Fellow of the American College of Physicians and Past-President of the Texas Infectious Disease Society.
Phillips J, Cardile AP, Patterson TF, Lewis JS. Daptomycin-induced acute eosinophilic pneumonia: Analysis of the current data and illustrative case reports Scand J Infect Dis 2013 Jul;.
Luo G, Gebremariam T, Lee H, French SW, Wiederhold NP, Patterson TF, Filler SG, Ibrahim AS. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis Antimicrob Agents. Chemother 2013 Jul;57(7):3340-3347.
Kauffman CA, Pappas PG, Patterson TF. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013 Jun;368(26):2495-2500.
Slama T, Kauffman CA, Patterson TF, Neill MA. Fungal outbreak update from IDWeek. Clin Infect Dis 2013 Mar;56(5):621-624.
Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol 2013 Feb;51(2):128-135.
Dufresne SF, Datta K, Li X, Dadachova E, Staab JF, Patterson TF, Feldmesser M, Marr KA. Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis. PLoS One 2012 Aug;7(8):42736-42736.
Thompson GR, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill JR, Patterson TF. A murine model of Cryptococcus gattii meningoencephalitis J Antimicrob Chemother 2012 Jun;67(6):1432-1438.
Kirkpatrick WR, Najvar LK, Vallor AC, Wiederhold NP, Bocanegra R, Pfeiffer J, Perkins K, Kugler AR, Sweeney TD, Patterson TF. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. J Antimicrob Chemother 2012 Apr;67(4):970-976.
Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Patterson TF. Comparison of anidulafungins and fluconazoles in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis. Clin Microbiol Infect 2012 Feb;18(2):E20-23.